As mentioned above, Nox2 is also associated with other abnormalities seen in the early stages of diabetic retinopathy including increase in inflammatory mediators, leukostasis and blood-retinal barrier damage, and inhibition of its activation will spare the retina from these metabolic abnormalities and prevent further progression of this blinding disease. The gene discussed is CYBB; the disease is diabetic retinopathy.